HCW Biologics Financial Overview
HCW Biologics's market cap is currently $5.32M. The company's EPS TTM is $-4.13; its P/E ratio is ―; HCW Biologics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-1.77. See an overview of income statement, balance sheet, and cash flow financials.
